Guanylyl cyclase receptors mediate cardiopulmonary vagal reflex actions of ANP

Hypertension

Volumn 41, Issue 2, 2003, Pages 279-285

  Thomas, Colleen J ^a   Woods, Robyn L ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Atrial natriuretic factor; Autonomic nervous system; Baroreflex; Bradycardia; Cyclic GMP; Natriuretic peptides

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CYCLIC GMP; GUANYLATE CYCLASE; HS 142 1; METHOXAMINE; RECEPTOR; SEROTONIN;

ADOLESCENT; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BRADYCARDIA; CARDIOPULMONARY HEMODYNAMICS; CONTROLLED STUDY; HEART INFARCTION; NONHUMAN; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RAT; VAGUS REFLEX;

ANIMALS; ATRIAL NATRIURETIC FACTOR; BLOOD PRESSURE; CONSCIOUSNESS; DOSE-RESPONSE RELATIONSHIP, DRUG; GUANYLATE CYCLASE; HEART; HEART RATE; LUNG; PEPTIDE FRAGMENTS; POLYSACCHARIDES; PRESSORECEPTORS; RATS; RATS, WISTAR; RECEPTORS, ATRIAL NATRIURETIC FACTOR; REFLEX; SEROTONIN; TETRAHYDROISOQUINOLINES; VAGUS NERVE;

EID: 0037318327     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000051501.20424.5D     Document Type: Article

References (43)

1. Woods RL, Courneya CA, Head GA. Nonuniform enhancement of baroreflex sensitivity by atrial natriuretic peptide in conscious rats and dogs. Am J Physiol. 1994;267:R678-R686.
2. Thomas CJ, Rankin AJ, Head GA, Woods RL. ANP enhances brady-cardic reflexes in normotensive but not spontaneously hypertensive rats. Hypertension. 1997;29:1126-1132.
3. Thomas CJ, Head GA, Woods RL. ANP and bradycardic reflexes in hypertensive rats: influence of cardiac hypertrophy. Hypertension. 1998;32:548-555.
4. Thomas CJ, Head GA, Woods RL. Similar baroreflex bradycardic actions of atrial natriuretic peptide and B and C types of natriuretic peptides in conscious rats. J Hypertens. 1999;17:801-806.
5. Thomas CJ, May CN, Sharma AD, Woods RL. ANP, BNP, and CNP enhance bradycardic responses to cardiopulmonary chemoreceptor activation in conscious sheep. Am J Physiol. 2001;280:R282-R288.
6. Volpe M. Atrial natriuretic peptide and the baroreflex control of circulation. Am J Hypertens. 1992;5:488-493.
7. Clemo HF, Baumgarten CM, Ellenbogen KA, Stambler BS. Atrial natriuretic peptide and cardiac electrophysiology: autonomic and direct effects. J Cardiovasc Electrophysiol. 1996;7:149-162.
8. Koller KJ, Goeddel DV. Molecular biology of the natriuretic peptides and their receptors. Circulation. 1992;86:1081-1088.
9. Trachte GJ. Physiology of the clearance receptor. In: Samson WK, Levin ER, eds. Contemporary Endocrinology: Natriuretic Peptides in Health and Disease. Totowa, NJ: Humana Press Inc; 1997:259-274.
10. Zhang PL, Jimenez W, Mackenzie HS, Guo J, Troy JL, Ros J, Angeli P, Arroyo V, Brenner BM. HS-142-1, a potent antagonist of natriuretic peptides in vitro and in vivo. J Am Soc Nephrol. 1994;5:1099-1105.
11. Anand-Srivastava MB. Atrial natriuretic peptide-C receptor and membrane signalling in hypertension. J Hypertens. 1997;15:815-826.
12. Schulz S. Targeted gene disruption in the development of mouse models to elucidate the role of receptor guanylyl cyclase signaling pathways in physiological function. Methods. 1999;19:551-558.
13. Melo LG, Steinhelper ME, Pang SC, Tse Y, Ackermann U. ANP in regulation of arterial pressure and fluid-electrolyte balance: lessons from genetic mouse models. Physiol Genom. 2000;3:45-58.
14. Izumi T, Saito Y, Kishimoto I, Harada M, Kuwahara K, Hamanaka I. Takahashi N, Kawakami R, Li Y, Takemura G, Fujiwara H, Garbers DL, Mochizuki S, Nakao K. Blockade of the natriuretic peptide receptor guanylyl cyclase-A inhibits NF-kappaB activation and alleviates myocardial ischemia/reperfusion injury. J Clin Invest. 2001;108:203-213.
15. Pedram A, Razandi M, Levin ER. Natriuretic peptides suppress vascular endothelial cell growth factor signaling to angiogenesis. Endocrinology. 2001;142:1578-1586.
16. Morishita Y, Sano T, Ando K, Saitoh Y, Kase H, Yamada K, Matsuda Y. Microbial polysaccharide, HS-142-1, competitively and selectively inhibits ANP binding to its guanylyl cyclase-containing receptor. Biochem Biophys Res Commun. 1991;176:949-957.
17. Imura R, Sano T, Goto J, Yamada K, Matsuda Y. Inhibition by HS-142-1, a novel nonpeptide atrial natriuretic peptide antagonist of microbial origin, of atrial natriuretic peptide-induced relaxation of isolated rabbit aorta through the blockade of guanylyl cyclase-linked receptors. Mol Pharmacol. 1992;42:982-990.
18. Sano T, Morishita Y, Yamada K. Matsuda Y. Effects of HS-142-1, a novel non-peptide ANP antagonist, on diuresis and natriuresis induced by acute volume expansion in anesthetized rats. Biochem Biophys Res Commun. 1992;182:824-829.
19. von Geldern TW, Budzik GP, Dillon TP, Holleman WH, Holst MA, Kiso Y, Novosad El, Opgenorth TJ, Rockway TW, Thomas AM, Yeh S. Atrial natriuretic peptide antagonists: biological evaluation and structural correlations. Mol Pharmacol. 1990;38:771-778.
20. Sultanian R, Deng Y, Kaufman S. Atrial natriuretic factor increases splenic microvascular pressure and fluid extravasation in the rat. J Physiol. 2001;533:273-280.
21. Delporte C, Winand J, Poloczek P, Von Geldern T, Christophe J. Discovery of a potent atrial natriuretic peptide antagonist for ANPA receptors in the human neuroblastoma NB-OK-1 cell line. Eur J Pharmacol. 1992;224:183-188.
22. Sinnayah P, Burns P, Wade JD, Weisinger RS, McKinley MJ. Water drinking in rats resulting from intravenous relaxin and its modification by other dipsogenic factors. Endocrinology. 1999;140:5082-5086.
23. Thomas CJ, Allen AM, McAllen RM, Woods RL. ANP potentiates nonarterial baroreflex bradycardia: evidence from sinoaortic denervation in rats. Auton Neurosci. 2002;97:89-98.
24. McKinley MJ, Allen AM, Burns P, Colvill LM, Oldfield BJ. Interaction of circulating hormones with the brain: the roles of the subfornical organ and the organum vasculosum of the lamina terminalis. Clin Exp Pharmacol Physiol. 1998;25:S61-S67.
25. Konrad EM, Thibault G, Schiffrin EL. Atrial natriuretic factor binding sites in rat area postrema: autoradiographic study. Am J Physiol. 1992;263:R747-R755.
26. Mokrane A, Nadeau R. Dynamics of heart rate response to sympathetic nerve stimulation. Am J Physiol. 1998;275:H995-H1001.
27. Atchison DJ, Ackermann U. Influence of atrial natriuretic factor on autonomic control of heart rate. Am J Physiol. 1990;258:R718-R723.
28. Herring N, Zaman JA, Paterson DJ. Natriuretic peptides like NO facilitate cardiac vagal neurotransmission and bradycardia via a cGMP pathway. Am J Physiol 2001;281:H2318-H2327.
29. Atchison DJ, Ackermann U. The interaction between atrial natriuretic peptide and cardiac parasympathetic function. J Auton Nerv Syst. 1993;42:81-88.
30. Jones JFX, Wang Y, Jordan D. Activity of C fire vagal efferents in anaesthetised cats and rats. J Physiol. 1998;507:869-880.
31. Schultz HD, Gardner DG, Deschepper CF, Coleridge HM, Coleridge JC. Vagal C-fiber blockade abolishes sympathetic inhibition via atrial natriuretic factor. Am J Physiol. 1988;255:R6-R13.
32. Casco VH, Neinot JP, Kuroski de Bold ML, Masters RG, Stevenson MM, de Bold AJ. Natriuretic peptide system gene expression in human coronary arteries. J Histochem Cytochem. 2002;50:799-800.
33. Nunez DJ, Dickson MC, Brown MJ. Natriuretic peptide receptor mRNAs in the rat and human heart. J Clin Invest. 1992;90:1966-1971.
34. Lin X, Hanze J, Heese F, Sodmann R, Lang RE. Gene expression of natriuretic peptide receptors in myocardial cells. Circ Res. 1995;77:750-758.
35. Deliva RD, Ackermann U. Atrial natriuretic peptide and mechanisms of cardiovascular control: role of serotonergic receptors. Am J Physiol. 1998;274:R711-R717.
36. 3 receptors synthesized in the rat CNS and peripheral nervous system. J Neurosci. 2002;22:6732-6741.
37. Endlich K, Steinhausen M. Natriuretic peptide receptors mediate different responses in rat renal microvessels. Kidney Int. 1997;52:202-207.
38. Okwueze MI, Opgenorth TJ, von Geldern TW, Vari RC. Atrial natriuretic peptide and glomerular hyperfiltration during onset of spontaneous diabetes mellitus. Am J Physiol. 1994;266:R572-R577.
39. Trachte GJ. Atrial natriuretic factor alters neurotransmission independently of guanylate cyclase-coupled receptors in the rabbit vas deferens. J Pharmacol Exp Ther. 1993;264:1227-1233.
40. Thames M, Dibner-Dunlop M, Minis A. Cardiovascular reflexes during myocardial ischaemia and infarction. In: Mark R, Hainsworth R, eds. Cardiovascular Reflex Control in Health and Disease. London, UK: WB Saunders Co: 1993:235-255.
41. Mark AL. The Bezold-Jarisch reflex revisited: clinical implications of inhibitory reflexes originating in the heart. J Am Coll Cardiol. 1983;1:90-102.
42. Kim SZ, Cho KW, Kim SH. Modulation of endocardial natriuretic peptide receptors in right ventricular hypertrophy. Am J Physiol. 1999;277:H2280-H2289.
43. Tuinenburg AE, Brundel BJ, Van Gelder IC, Henning RH, Van Den Berg MP, Driessen C, Grandjean JG, Van Gilst WH, Crijns HJ. Gene expression of the natriuretic peptide system in atrial tissue of patients with paroxysmal and persistent atrial fibrillation. J Cardiovasc Electrophysiol. 1999;10:827-835.